ライフサイエンスコーパス: PHI

1 PHI and VIP inhibited proliferation at concentrations as

2 PHI could change according to the application time, beca

3 PHI manifested with typical ARS in 202 (70%) and with at

4 PHI scores were measured in men undergoing re-biopsy wit

5 PHI-base is available at: http://www.phi-base.org/.

6 PHI-base is the first on-line resource devoted to the id

7 PHI-base is therefore an invaluable resource for the dis

8 PHI-base phenotypes were mapped via their associated gen

9 PHI-BLAST is applied to the analysis of CED4-like cell d

10 PHI-BLAST searches a protein database for other instance

11 At a threshold of >/=35, PHI + mpMRI demonstrated a NPV of 0.97 for excluding sig

12 Samples from 14 healthy donors (HDs), 40 PHI patients, 17 Chronics, and 13 Elite controllers (ECs

13 C-PS and (12)C-PS were also analyzed using a PHI TRIFT I time-of-flight mass spectrometer, with 15-ke

14 Using a PHI>/=35, only 1/21 significant cancers was missed and 3

15 In this study adding PHI to mpMRI improved overall and significant cancer pre

16 Discovery of PHI-1 and PHI-2 opens new possibilities for regulation of PP1 via

17 ferring sites, bivalent VIP/PACAP sites, and PHI-binding sites that did not interact with VIP.

18 Genes with associated PHI-base data can be easily identified across all plant

19 ere assessed for those who initiated cART at PHI diagnosis.

20 Because PHIs are able to increase erythroblast production at ver

21 se efforts, the pattern-hit initiated BLAST (PHI-BLAST) program described here takes as input both a

22 Tracking of individual FGF2 by PHI in the pericellular matrix of living cells demonstra

23 Furthermore, the calculated PHI values, according to the maximum residue levels set

24 discovery of a new inhibitor protein called PHI-1 that is specific for type-1 protein phosphatase (P

25 ll lines, and a second larger protein called PHI-2 was present in different muscles, especially cardi

26 The number of fields that characterize PHI-base entries has almost doubled.

27 The study population comprised PHI patients enrolled in the ANRS-PRIMO-cohort.

28 that contain radiologic images often contain PHI, and this may violate laws, including the U.S. Healt

29 with images, image links, or notes contained PHI.

30 diologic images; 34 (40%) of these contained PHI, and 19 (22%) showed the patient's name.

31 diologic images; 51 (40%) of these contained PHI, and 31 (24%) showed the patient's name.

32 s, or notes, and 52 (36%) of these contained PHI.

33 The pathogen-host interaction database (PHI-base) is a web-accessible database that catalogues e

34 The Pathogen-Host Interactions database (PHI-base) catalogues experimentally verified pathogenici

35 The pathogen-host interactions database (PHI-base) is available at www.phi-base.org PHI-base cont

36 hen performing dissipation studies to define PHI.

37 to trigger host responses, we have developed PHI-base.

38 tively enrolled 290 patients with documented PHI in the Zurich Primary HIV Infection Study.

39 reservoir in patients initiating cART during PHI and to assess the impact of the timing of cART initi

40 -lymphocyte (CTL) responses developed during PHI in comparison to CTL responses in chronic infection

41 We included patients enrolled during PHI in the Agence Nationale de Recherche sur le Sida PRI

42 Diagnosing HIV during PHI can markedly reduce transmission by changing transmi

43 ths of high-dose zidovudine initiated during PHI results in higher CD4 cell counts and lower PBMC cul

44 CTL responses during PHI followed clear hierarchical immunodominance patterns

45 ntacts may overestimate transmissions during PHI for real, dynamic sexual partnerships with varying (

46 The fraction of transmissions during PHI has a U-shaped relationship with respect to the rate

47 ion of gp41-induced membrane fusion by early PHI conformation and fusion arrest after folding to the

48 P may therefore be associated with the early PHI conformation and FP withdrawal with the final hairpi

49 Okra samples harvested after the estimated PHIs were found safe for human consumption.

50 between level of cognitive decline following PHI and the possession of certain genetic markers that h

51 Future plans for PHI-base include development of tools facilitating commu

52 at integrates phenotypic data for genes from PHI-base, an expertly curated catalog of genes with expe

53 very low concentrations of glucocorticoids, PHI-induced stimulation of BFU-E progenitors thus repres

54 HIF PHIs represent a novel class of molecules with broad pot

55 If PHI lasts for 3 months and testing is performed monthly,

56 roscopy and photothermal heterodyne imaging (PHI) show that the spatial distribution of the HS-bindin

57 Each entry in PHI-base is curated by domain experts and supported by s

58 Finally, in PHI patients the VL set point was a significant predicto

59 Each gene in PHI-base is presented with its nucleotide and deduced am

60 We welcome new data for inclusion in PHI-base, which is freely accessed at www4.rothamsted.bb

61 sample, mean +/- standard deviation) than in PHI patients (0.066 +/- 0.09/VL sample).

62 c MRI (mpMRI) and the Prostate Health Index (PHI) have shown promise in predicting a positive biopsy

63 Primary HIV-1 infection (PHI) is marked by a flu-like syndrome and high levels of

64 an immunodeficiency virus (HIV)-1 infection (PHI) to receive zidovudine, 1000 mg daily, or placebo fo

65 y infected cells in primary HIV-1 infection (PHI) would predict clinical progression and viral replic

66 man immunodeficiency virus type 1 infection (PHI), diagnosed in France (1996-2010).

67 ges of HIV infection: primary HIV infection (PHI) and chronic stage.

68 during (acute/early) primary HIV infection (PHI) and up to one year post-infection (p.i).

69 within the CNS during primary HIV infection (PHI) has not been characterized.

70 itiating HAART during primary HIV infection (PHI) or chronic HIV infection (CHI) using flow cytometry

71 jects enrolled during primary HIV infection (PHI), 10 chronically infected subjects (chronic), and 7

72 ing highly infectious primary HIV infection (PHI), we developed a stochastic individual-based model t

73 uman immunodeficiency virus (HIV) infection (PHI) have not been published.

74 uman immunodeficiency virus (HIV) infection (PHI) yields a larger decrease in cell-associated HIV-DNA

75 ly infected patients (primary HIV infection [PHI] group) who started therapy within 6 months of the o

76 se or disclose protected health information (PHI).

77 ctivation by a prolyl hydroxylase inhibitor (PHI) synergizes with glucocorticoids and enhances produc

78 exposure to a small molecule PHD inhibitor (PHI) (2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido) a

79 Unlike any other known inhibitor, PHI-1 inhibited the myosin- and glycogen-associated holo

80 Several HIF-prolyl hydroxylase inhibitors (PHIs) induced erythropoietin (epo) expression in vitro a

81 with predominantly penetrating head injury (PHI) suffered more than 30 years ago.

82 s include an early pre-hairpin intermediate (PHI) characterized by extended coiled-coil structure in

83 e accessible in the prehairpin intermediate (PHI) state and block the formation of the six-helix bund

84 refusion state to a prehairpin intermediate (PHI), while the second phase is marked by transition fro

85 ce of fluopyram at the pre-harvest interval (PHI) of 7-21 d was between 0.0108 and 0.1603 mg/kg, and

86 degradation rates, the pre-harvest interval (PHI) values and the half-life values of the three pestic

87 The estimated pre-harvest intervals (PHI) for fipronil and difenoconazole were 15 and 19.5day

88 were studied and the pre-harvest intervals (PHIs) were calculated.

89 sidues dissipated with preharvest intervals (PHIs) of 33.5, 12 and 32 days at recommended dose with n

90 irectly curate their own published data into PHI-base.

91 Additional data types included into PHI-base 4 are the direct targets of pathogen effector p

92 peptide (VIP), peptide histidine isoleucine (PHI) and gastrin-releasing peptide (GRP).

93 d the level of peptide histidine isoleucine (PHI), a peptide coded for by the same mRNA that encodes

94 peptide (VIP), peptide histidine isoleucine (PHI), and pituitary adenylate cyclase-activating peptide

95 e neuroleukin (NLK)/phosphohexose isomerase (PHI)/maturation factor (MF) polypeptide.

96 ly after removal of plasma IgA from 12-month PHI samples: the magnitude of ADCC not only increased af

97 The cDNA sequences of AMF/NLK/PHI/MF found in both human cancer and normal cells were

98 sion, secretion, and distribution of AMF/NLK/PHI/MF in neoplastic and their normal counterpart cells.

99 ochemical visualization has depicted AMF/NLK/PHI/MF to be localized into tubular-like vesicles, diffu

100 No PHI of imidacloprid is required, while for oxamyl it was

101 , 12 and 32 days at recommended dose with no PHI applicable for GA3.

102 80% of PHI enrollment samples and in 100% of PHI 12-month, chronic, and EC samples; it peaked after a

103 ADCC was documented in 80% of PHI enrollment samples and in 100% of PHI 12-month, chro

104 egies to increase detection and diagnoses of PHI.

105 Discovery of PHI-1 and PHI-2 opens new possibilities for regulation o

106 The random distribution of PHI-BLAST alignment scores is studied analytically and e

107 31-45 to 15-23 events; a shorter duration of PHI and/or a lower testing frequency reduces the number

108 f the high infectivity but short duration of PHI, even short-term behavior change can significantly r

109 al suppression was more effective in GALT of PHI patients than CHI patients during HAART.

110 ter HIV transmission, though a proportion of PHI patients demonstrate relatively reduced CSF HIV RNA

111 The new release of PHI-base Version 4.2 (October 2016) has an increased dat

112 n in the 3 months after infection depends on PHI duration and testing frequency.

113 One PHI, FG-2216, was further tested in a nonhuman primate m

114 (PHI-base) is available at www.phi-base.org PHI-base contains expertly curated molecular and biologi

115 vels of CSF inflammation lower than in other PHI participants but higher than in HIV-seronegative con

116 onstrate potent regulatory actions of PACAP, PHI, and VIP on neuroblastoma cell proliferation which a

117 ding experiments using 125I-labeled PACAP27, PHI, and VIP, demonstrated the presence of PACAP-preferr

118 h stages on the Pre-harvest Interval Period (PHI).

119 mediated by CPI-17 and its related proteins, PHI, KEPI, and GBPI, are discussed.

120 ized a NiV heptad repeat peptide to quantify PHI formation and the half-lives (t(1/2)) of the first a

121 largely due to an enhanced dynamic response (PHId), and a more than twofold improvement in glucose to

122 Here we describe a revised PHI-base Version 4 data platform with improved search, f

123 Furthermore, several PHIs induced fetal hemoglobin (HbF) expression in primar

124 ring the responses of patients treated since PHI and showing a similar virological and immunological

125 As such, PHI-base is a valuable resource for the discovery of can

126 Recombinant tagged PHI-1 was phosphorylated by protein kinase C at two site

127 Immunoblotting showed that PHI-1 was expressed in most animal tissues and several c

128 The PHI can be captured with peptides that mimic F's heptad

129 The PHI participants (median 77 days post transmission) had

130 The PHI was assessed for ability to add value to mpMRI in pr

131 The presentations were examined for the PHI contained on any images, links, or notes pages.

132 econd phase is marked by transition from the PHI to the six-helix-bundle hairpin.

133 In mpMRI negative men, the PHI again improved prediction of significant cancers; AU

134 ontained the FP and respectively modeled the PHI and hairpin conformations.

135 onstrated clinically relevant utility of the PHI across threshold probabilities of 5-30%.

136 Further, 7 day administration of the PHI induced only modest increases in HVR and carotid bod

137 encountered and the future directions of the PHI-base project are briefly discussed.

138 o associated with pathogenicity based on the PHI-base database.

139 ,g)), disrupts the trimer and sequesters the PHI through the formation of heterotrimers.

140 In summary, the PHI adds predictive performance to image-guided detectio

141 The data obtained indicated that the PHI-inhibitory and PACAP-stimulatory activities were med

142 The PHIs successfully minimised residue problems as observed

143 ST search function is provided and a link to PHI-Canto, a tool for authors to directly curate their o

144 psis, is structurally related to the tobacco PHI-1 gene, which is re-activated in cultured cells foll

145 dentifying members of this superfamily using PHI-BLAST.

146 The current version, PHI-base 3.6, available at http://www.phi-base.org, stor

147 ection of a peptide cocktail containing VIP, PHI, GRP.

148 , isoproterenol did not alter levels of VIP, PHI, or VIP-PHI mRNA.

149 the actions of exogenous VIP on cAMP and VIP-PHI mRNA in neuron-enriched cultures.

150 significantly inhibited the increase in VIP-PHI mRNA that normally occurs.

151 VIP or forskolin also increased VIP-PHI mRNA.

152 nol did not alter levels of VIP, PHI, or VIP-PHI mRNA.

153 ators should know the conditions under which PHI may be accessed for research purposes (ie, with auth

154 ed randomised population of individuals with PHI.

155 id (CSF) and blood from 96 participants with PHI and compared them with samples from neuroasymptomati

156 ccurred in a large fraction of patients with PHI and were associated with substantial morbidity.

157 ression procedures, we found that those with PHI demonstrated a greater degree of cognitive decline o

158 decline does occur in Vietnam veterans with PHI and it is apparently unrelated to dementia and is de